Bio Essence Corporation
BIOE
$0.0937
$0.00272.97%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -132.59% | -150.13% | -34.69% | -48.79% | 32.59% |
| Total Depreciation and Amortization | 104.55% | -70.37% | -74.47% | -349.15% | -222.22% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15,062.35% | 8,204.09% | 452.38% | 332.90% | -103.29% |
| Change in Net Operating Assets | 1,193.69% | 452.82% | 414.80% | 242.63% | 28.19% |
| Cash from Operations | 230.73% | 179.69% | 160.83% | 99.65% | 4.21% |
| Capital Expenditure | -- | -- | -- | -100.00% | -63.64% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 99.89% | 99.89% | 99.89% | -865.93% | -58.85% |
| Total Debt Issued | -71.62% | -86.55% | -100.00% | -68.29% | -5.63% |
| Total Debt Repaid | -2,833.10% | -8,542.06% | -47,061.54% | -346.74% | 188.09% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 100.00% | 86.34% | -1,014.74% | -1,014.74% |
| Cash from Financing | -215.59% | -172.79% | -156.03% | -87.39% | 1.45% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -206.59% | -- | 119.67% | 6,080.00% | 1,720.00% |